|
US5080898A
(en)
|
1982-05-12 |
1992-01-14 |
The University Hospital |
Enzymatically active toxin coupled to a cell-specific ligand
|
|
US4894443A
(en)
|
1984-02-08 |
1990-01-16 |
Cetus Corporation |
Toxin conjugates
|
|
US5668255A
(en)
|
1984-06-07 |
1997-09-16 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
US6022950A
(en)
|
1984-06-07 |
2000-02-08 |
Seragen, Inc. |
Hybrid molecules having translocation region and cell-binding region
|
|
US5091178A
(en)
|
1986-02-21 |
1992-02-25 |
Oncogen |
Tumor therapy with biologically active anti-tumor antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5135736A
(en)
|
1988-08-15 |
1992-08-04 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
|
WO1991009871A1
(en)
|
1989-12-22 |
1991-07-11 |
Seragen Incorporated |
Hybrid molecules having translocation region and cell-binding region
|
|
US5635384A
(en)
|
1990-06-11 |
1997-06-03 |
Dowelanco |
Ribosome-inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
|
|
US5621083A
(en)
|
1991-11-04 |
1997-04-15 |
Xoma Corporation |
Immunotoxins comprising ribosome-inactivating proteins
|
|
US6146850A
(en)
|
1991-11-04 |
2000-11-14 |
Xoma Corporation |
Proteins encoding gelonin sequences
|
|
WO1994026910A1
(en)
|
1993-05-12 |
1994-11-24 |
Xoma Corporation |
Immunotoxins comprising gelonin and an antibody
|
|
US5552144A
(en)
|
1992-01-22 |
1996-09-03 |
Microcarb, Inc. |
Immunogenic shiga-like toxin II variant mutants
|
|
US5612474A
(en)
|
1994-06-30 |
1997-03-18 |
Eli Lilly And Company |
Acid labile immunoconjugate intermediates
|
|
AU3374795A
(en)
|
1994-08-29 |
1996-03-22 |
Prizm Pharmaceuticals, Inc. |
Conjugates of vascular endothelial growth factor with targeted agents
|
|
AU5431196A
(en)
|
1995-03-24 |
1996-10-16 |
Ophidian Pharmaceuticals |
Treatment for verotoxin-producing escherichia coli
|
|
US5667786A
(en)
|
1995-06-07 |
1997-09-16 |
Novavax, Inc. |
Method for treating tumors with a toxin
|
|
US5858682A
(en)
|
1996-08-02 |
1999-01-12 |
Pharmingen |
E2A/pbx1 fusion protein specific monoclonal antibodies
|
|
CZ295838B6
(cs)
|
1996-09-09 |
2005-11-16 |
Zealand Pharma A/S |
Způsob výroby peptidů
|
|
WO1998011229A2
(en)
|
1996-09-10 |
1998-03-19 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
FR2766193B1
(fr)
|
1997-07-18 |
2001-09-14 |
Inst Curie |
Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
|
|
CA2222993A1
(en)
|
1998-02-04 |
1999-08-04 |
The Ontario Cancer Institute |
A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries
|
|
WO1999062526A2
(en)
|
1998-06-05 |
1999-12-09 |
Mayo Foundation For Medical Education And Research |
Use of genetically engineered antibodies to cd38 to treat multiple myeloma
|
|
US7157418B1
(en)
|
1998-07-22 |
2007-01-02 |
Osprey Pharmaceuticals, Ltd. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
|
AU2004202331A1
(en)
|
1998-07-22 |
2004-06-24 |
Osprey Pharmaceuticals Limited |
Methods and Compositions for Treating Secondary Tissue Damage and Other Inflammatory Conditions and Disorders
|
|
ES2205849T3
(es)
|
1998-07-22 |
2004-05-01 |
Osprey Pharmaceuticals Limited |
Conjugados para tratar alteraciones inflamatorias y asociadas con daños tisulares.
|
|
US6770456B1
(en)
|
1998-07-29 |
2004-08-03 |
Ludwig Institute For Cancer Research |
Endogenous retrovirus tumor associated nucleic acids and antigens
|
|
DE60040136D1
(de)
|
1999-03-16 |
2008-10-16 |
Us Gov Nat Inst Health |
Ein neues chimäres protein für die prävention und die behandlung einer hiv infektion
|
|
US7527787B2
(en)
|
2005-10-19 |
2009-05-05 |
Ibc Pharmaceuticals, Inc. |
Multivalent immunoglobulin-based bioactive assemblies
|
|
US7144991B2
(en)
|
1999-06-07 |
2006-12-05 |
Aletheon Pharmaceuticals, Inc. |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US6492498B1
(en)
|
1999-11-15 |
2002-12-10 |
Regents Of The University Of Minnesota |
Multimeric immunotoxins
|
|
US7267973B2
(en)
|
2000-03-22 |
2007-09-11 |
Sibtech, Inc. |
Nucleic acids encoding recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor
|
|
US20010031485A1
(en)
*
|
2000-03-22 |
2001-10-18 |
Sibtech, Inc. |
Recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor fragments
|
|
CN101289511A
(zh)
|
2000-04-11 |
2008-10-22 |
杰南技术公司 |
多价抗体及其应用
|
|
US20020127247A1
(en)
|
2000-11-17 |
2002-09-12 |
Allergen Sales, Inc. |
Modified clostridial neurotoxins with altered biological persistence
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
WO2003066854A1
(fr)
|
2002-02-04 |
2003-08-14 |
Yoshida, Hideo |
Agent anticancereux utilisant des variantes de verotoxines
|
|
US20050239043A1
(en)
|
2002-02-26 |
2005-10-27 |
Harding Fiona A |
Subtilisin carlsberg proteins with reduced immunogenicity
|
|
KR101017732B1
(ko)
|
2002-03-01 |
2011-02-28 |
이뮤노메딕스, 인코오포레이티드 |
내재화 항-ｃｄ74 항체 및 그 이용방법
|
|
ATE292144T1
(de)
|
2002-08-02 |
2005-04-15 |
Inst Curie |
Shiga-toxin-untereinheit b als vektor zur diagnose von tumoren und zur arzneimittelverabreichung an gb3-exprimierenden tumoren
|
|
EP3263596A1
(en)
|
2002-12-16 |
2018-01-03 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
|
US7875586B2
(en)
|
2002-12-20 |
2011-01-25 |
The Johns Hopkins University |
Treatment of metastatic colon cancer with b-subunit of shiga toxin
|
|
WO2005000902A1
(en)
|
2003-06-30 |
2005-01-06 |
Mu-Hyeon Choe |
The dimer of chimeric recombinant binding domain-functional group fusion formed via disulfide-bond-bridge and the processes for producing the same
|
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
|
EP1687016A4
(en)
|
2003-11-25 |
2009-07-29 |
Anjin Corp |
GENETIC VARIANT OF DIPHTHERIC TOXIN
|
|
US7982011B2
(en)
|
2003-11-25 |
2011-07-19 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Mutated anti-cd22 antibodies and immunoconjugates
|
|
US8263746B2
(en)
|
2004-02-06 |
2012-09-11 |
Morphosys Ag |
Anti-CD38 human antibodies and uses thereof
|
|
US20070298434A1
(en)
|
2004-03-26 |
2007-12-27 |
Jean Gariepy |
Library of Toxin Mutants, and Methods of Using Same
|
|
US8858930B2
(en)
*
|
2004-10-26 |
2014-10-14 |
Chengru Zhu |
Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle
|
|
EP2567976B1
(en)
|
2005-03-23 |
2017-07-19 |
Genmab A/S |
Antibodies against CD38 for treatment of multiple myeloma
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
FI20055417A0
(fi)
|
2005-07-20 |
2005-07-20 |
Glykos Finland Oy |
Syöpäpesifiset glykaanit ja niiden käyttö
|
|
JP2009502936A
(ja)
|
2005-07-25 |
2009-01-29 |
トルビオン ファーマシューティカルズ， インコーポレイテッド |
Ｃｄ２０特異的結合分子の単一投与量
|
|
AU2006279541A1
(en)
|
2005-08-15 |
2007-02-22 |
The Regents Of The University Of California |
VEGF-activated FAS ligands
|
|
ES2493465T3
(es)
|
2005-09-26 |
2014-09-11 |
Molecular Templates, Inc. |
Biblioteca a partir de toxinas mutantes y procesos de utilización de la misma
|
|
GB0524788D0
(en)
|
2005-12-05 |
2006-01-11 |
Affibody Ab |
Polypeptides
|
|
JP2009520468A
(ja)
|
2005-12-23 |
2009-05-28 |
ヴィヴェンティア バイオテック インコーポレーティッド |
融合タンパク質ライブラリーの作製法およびスクリーニング法、ならびにそれらの使用
|
|
JP5409014B2
(ja)
|
2006-02-16 |
2014-02-05 |
ザ ヘンリー エム． ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド |
志賀トキソイドキメラタンパク質
|
|
US7373982B2
(en)
|
2006-03-21 |
2008-05-20 |
Halliburton Energy Services, Inc. |
Cements for use across formations containing gas hydrates
|
|
WO2008073160A2
(en)
|
2006-08-17 |
2008-06-19 |
The Trustees Of Columbia University In The City Of New York |
Methods for converting or inducing protective immunity
|
|
CN101622352A
(zh)
*
|
2006-12-29 |
2010-01-06 |
美国奥斯普瑞医药公司 |
选择和产生修饰的毒素、含有修饰的毒素的缀合物的方法及其应用
|
|
BRPI0720647A2
(pt)
|
2006-12-29 |
2014-01-14 |
Osprey Pharmaceuticals Usa Inc |
Processos de seleção e produção de toxinas modificadas, conjugados contendo toxinas modificadas e usos dos mesmos
|
|
US7786267B2
(en)
|
2007-02-02 |
2010-08-31 |
Baylor Research Institute |
Multivariable antigens complexed with targeting humanized monoclonal antibody
|
|
GB2456904B8
(en)
*
|
2007-03-22 |
2009-12-09 |
Heptares Therapeutics Ltd |
Stable neurotensin receptor mutants
|
|
JP2010530895A
(ja)
|
2007-06-21 |
2010-09-16 |
アンジェリカ セラピューティックス，インク． |
修飾毒素
|
|
US7887801B2
(en)
|
2007-07-13 |
2011-02-15 |
Topotarget Germany Ag |
Optimized DNA and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins
|
|
WO2009017823A2
(en)
|
2007-08-01 |
2009-02-05 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
A fold-back diabody diphtheria toxin immunotoxin and methods of use
|
|
PL2197903T3
(pl)
|
2007-09-04 |
2015-03-31 |
Us Gov Health & Human Services |
Delecje w domenie ii egzotoksyny a psuedomonas zmniejszające toksyczność niespecyficzną
|
|
WO2009088403A2
(en)
|
2007-10-08 |
2009-07-16 |
Rutgers, The State University |
Nontoxic shiga-like toxin mutant compositions and methods
|
|
EP2048896B1
(en)
|
2007-10-12 |
2011-12-21 |
STMicroelectronics Srl |
Method and circuit for testing an audio high-frequency loudspeaker being part of a loudspeaker system
|
|
CA2705289A1
(en)
|
2007-11-13 |
2009-05-22 |
The Scripps Research Institute |
Production of cytotoxic antibody-toxin fusion in eukaryotic algae
|
|
EP2220120A2
(en)
|
2007-11-27 |
2010-08-25 |
Ablynx N.V. |
Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
|
|
JP5337815B2
(ja)
|
2007-12-17 |
2013-11-06 |
アンワイヤード プラネット エルエルシー |
多アンテナ受信機干渉除去方法及び装置
|
|
EP2268297A4
(en)
|
2008-02-29 |
2011-11-16 |
Angelica Therapeutics Inc |
MODIFIED TOXINS
|
|
CN101629158A
(zh)
*
|
2008-07-17 |
2010-01-20 |
冯书章 |
出血性大肠杆菌o157重组疫苗
|
|
JP6049163B2
(ja)
|
2008-07-21 |
2016-12-21 |
イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． |
改善された治療上の特徴のための抗体の構造変異体
|
|
US20100093563A1
(en)
|
2008-09-22 |
2010-04-15 |
Robert Anthony Williamson |
Methods and vectors for display of molecules and displayed molecules and collections
|
|
CN102257000B
(zh)
*
|
2008-10-21 |
2014-10-08 |
国际疫苗研究所 |
新型志贺氏菌蛋白抗原及方法
|
|
KR101832499B1
(ko)
|
2009-01-23 |
2018-02-26 |
더 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신, 인코포레이티드 |
시가 독소 2형 단백질 기반 방법 및 조성물
|
|
US9034341B2
(en)
|
2009-04-20 |
2015-05-19 |
Transtech Pharma, Llc |
Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions
|
|
US20120258104A1
(en)
|
2009-07-22 |
2012-10-11 |
Cenix Bioscience Gmbh |
Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes
|
|
EP2464836A2
(en)
|
2009-08-14 |
2012-06-20 |
Unifrax I LLC |
Mounting mat for exhaust gas treatment device
|
|
EP2371864A1
(en)
|
2010-03-23 |
2011-10-05 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies for treatment of cancer
|
|
CN114805583A
(zh)
|
2010-05-27 |
2022-07-29 |
根马布股份公司 |
针对her2的单克隆抗体
|
|
GB201013989D0
(en)
|
2010-08-20 |
2010-10-06 |
Univ Southampton |
Biological materials and methods of using the same
|
|
US9321847B2
(en)
|
2010-09-20 |
2016-04-26 |
Ramot At Tel Aviv University Ltd. |
Activatable toxin complexes comprising a cleavable inhibitory peptide
|
|
PL219845B1
(pl)
|
2011-01-05 |
2015-07-31 |
Adamed Spółka Z Ograniczoną Odpowiedzialnością |
Przeciwnowotworowe białko fuzyjne
|
|
EP2476441A1
(en)
*
|
2011-01-13 |
2012-07-18 |
Universitat Autònoma De Barcelona |
Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
|
|
CA2825023A1
(en)
|
2011-01-26 |
2012-08-02 |
Cenix Bioscience Gmbh |
Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
|
|
WO2012104344A1
(en)
|
2011-02-01 |
2012-08-09 |
Genmab A/S |
Human antibodies and antibody-drug conjugates against cd74
|
|
CA2827170A1
(en)
|
2011-02-11 |
2012-08-16 |
David M. Hilbert |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
US8895006B2
(en)
*
|
2011-03-04 |
2014-11-25 |
Rutgers, The State University Of New Jersey |
Ricin ribosome binding protein compositions and methods of use thereof
|
|
RU2600067C2
(ru)
|
2011-05-06 |
2016-10-20 |
Дзе Гавермент Оф Дзе Юнайтед Стейтс Оф Америка Эз Репрезентед Бай Дзе Секретари Оф Дзе Депармент Оф Хелс Энд Хьюман Сёрвисез |
Рекомбинантный иммунотоксин, нацеленный на мезотелин
|
|
WO2012162418A1
(en)
|
2011-05-23 |
2012-11-29 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for heterodimeric targeting ligands
|
|
PL397167A1
(pl)
|
2011-11-28 |
2013-06-10 |
Adamed Spólka Z Ograniczona Odpowiedzialnoscia |
Przeciwnowotworowe bialko fuzyjne
|
|
EP2817341A4
(en)
|
2012-02-23 |
2015-12-02 |
Harvard College |
MICROBIAL MODIFIED TOXIN RECEPTOR FOR THE DISTRIBUTION OF AGENTS IN CELLS
|
|
JP2014021782A
(ja)
|
2012-07-19 |
2014-02-03 |
Canon Inc |
画像処理装置、その制御方法及びプログラム
|
|
EP2740493A1
(en)
|
2012-12-05 |
2014-06-11 |
Institut Curie |
Conjugates of the B-subunit of Shiga toxin for anticancer therapies
|
|
RS60280B1
(sr)
|
2013-03-12 |
2020-06-30 |
Molecular Templates Inc |
Citotoksični proteini koji sadrže ciljane vezujuće regione za ćelije i regioni shiga toksina a podjedinice za selektivno ubijanje određenih vrsta ćelija
|
|
EP2778173A1
(en)
|
2013-03-15 |
2014-09-17 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Antibody directed against anthrax toxins and its uses
|
|
GB2519786A
(en)
|
2013-10-30 |
2015-05-06 |
Sergej Michailovic Kiprijanov |
Multivalent antigen-binding protein molecules
|
|
US20160177284A1
(en)
|
2014-01-27 |
2016-06-23 |
Molecular Templates, Inc. |
Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions
|
|
US20210138076A2
(en)
|
2014-01-27 |
2021-05-13 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
US20220401568A1
(en)
|
2014-01-27 |
2022-12-22 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
WO2017019623A2
(en)
|
2015-07-26 |
2017-02-02 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
CN111909278B
(zh)
*
|
2014-01-27 |
2024-04-09 |
分子模板公司 |
Mhc i类表位递送多肽
|
|
US10421958B2
(en)
|
2014-02-05 |
2019-09-24 |
Molecular Templates, Inc. |
Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
|
|
US11142584B2
(en)
|
2014-03-11 |
2021-10-12 |
Molecular Templates, Inc. |
CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
|
|
ES2723774T3
(es)
|
2014-03-11 |
2019-09-02 |
Molecular Templates Inc |
Proteínas que comprenden regiones de unión, regiones efectoras de la subunidad A de toxina Shiga y motivos señal de localización de retículo endoplasmático carboxi terminal
|
|
AU2015229583B2
(en)
|
2014-03-11 |
2020-07-09 |
Molecular Templates, Inc. |
Proteins comprising amino-terminal proximal Shiga toxin A Subunit effector regions and cell-targeting immunoglobulin-type binding regions
|
|
JP6643545B2
(ja)
|
2014-03-14 |
2020-02-12 |
ラクオリア創薬株式会社 |
Ｔｒｐｍ８拮抗剤としてのアザスピロ誘導体
|
|
ES2919749T3
(es)
|
2014-06-11 |
2022-07-28 |
Molecular Templates Inc |
Moléculas dirigidas a células citotóxicas resistentes a la escisión por proteasa
|
|
KR102451080B1
(ko)
|
2014-06-12 |
2022-10-06 |
씨에스피씨 메가리스 바이오파마슈티칼 씨오., 엘티디. |
효소적 방법을 통한 균일한 항체 약물 접합체
|
|
EP3157958B1
(en)
|
2014-06-18 |
2020-05-06 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Car-expressing nk-92 cells as cell therapeutic agents
|
|
CN105713087B
(zh)
|
2014-11-12 |
2020-05-08 |
北京康乐卫士生物技术股份有限公司 |
人乳头瘤病毒58型单克隆抗体及其应用
|
|
MX2017010072A
(es)
|
2015-02-05 |
2017-11-09 |
Molecular Templates Inc |
Moleculas multivalentes que se enlazan a cd20, las cuales comprenden regiones efectoras de la subunidad a de la toxina shiga, y composiciones enriquecidas de las mismas.
|
|
KR102357312B1
(ko)
|
2015-03-04 |
2022-02-03 |
아이쥐엠 바이오사이언스 인코포레이티드 |
Ｃｄ20 결합 분자 및 그의 용도
|
|
AU2016271124C1
(en)
|
2015-05-30 |
2020-05-14 |
Molecular Templates, Inc. |
De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same
|
|
KR102418372B1
(ko)
|
2016-03-29 |
2022-07-08 |
주식회사 에스티큐브 |
글리코실화된 pd-l1에 특이적인 이중 기능 항체 및 이의 사용 방법
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
CN117088979A
(zh)
|
2016-10-30 |
2023-11-21 |
上海复宏汉霖生物技术股份有限公司 |
抗-pd-l1抗体及变异体
|
|
WO2018106895A1
(en)
*
|
2016-12-07 |
2018-06-14 |
Molecular Templates, Inc. |
Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
|
|
WO2018124642A2
(ko)
|
2016-12-26 |
2018-07-05 |
단국대학교 천안캠퍼스 산학협력단 |
치수줄기세포의 상아 모전구세포로의 분화용 조성물 및 상아모전구세포 표면에 특이적으로 결합하는 IgG 또는 IgM 타입 단일 클론 항체
|
|
EP3573648B1
(en)
|
2017-01-25 |
2023-11-22 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising de-immunized, shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
US20200190138A1
(en)
|
2017-02-28 |
2020-06-18 |
Chugai Seiyaku Kabushiki Kaisha |
Protein purification with protein l
|
|
BR112019018533A2
(pt)
|
2017-03-09 |
2020-04-14 |
Genmab A/S |
anticorpo, construção de ácido nucleico, vetor de expressão, célula hospedeira, composição farmacêutica, método para tratar uma doença, e, uso de um anticorpo
|
|
CN111108113B
(zh)
|
2017-09-25 |
2024-02-23 |
Jsr株式会社 |
免疫球蛋白结合蛋白质和使用其的亲和载体
|
|
AU2019257343A1
(en)
|
2018-04-17 |
2020-09-10 |
Molecular Templates, Inc. |
HER2-targeting molecules comprising de-immunized, Shiga toxin A Subunit scaffolds
|
|
WO2020081493A1
(en)
|
2018-10-16 |
2020-04-23 |
Molecular Templates, Inc. |
Pd-l1 binding proteins
|
|
WO2020154475A1
(en)
|
2019-01-23 |
2020-07-30 |
Molecular Templates, Inc. |
Proteins comprising modified immunoglobulin variable light chains
|
|
CN113454108B
(zh)
*
|
2019-01-23 |
2025-02-14 |
米伦纽姆医药公司 |
包含去免疫化志贺菌毒素a亚基效应子的cd38结合蛋白
|
|
CN114423793A
(zh)
|
2019-09-18 |
2022-04-29 |
分子模板公司 |
包含志贺菌毒素a亚基支架的pd-l1结合分子
|
|
WO2022197945A1
(en)
|
2021-03-17 |
2022-09-22 |
Molecular Templates, Inc. |
Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t cell antigens
|